Integrated Cervical Self-Sampling for Cytology, High-Risk Human Papillomavirus, and Sexually Transmitted Infection Testing: A Prospective Study
Diagnostics · 16.06.2026 · 16 (12) · 1863
DOI: 10.3390/diagnostics16121863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.06.2026. Verfasst von Chang Gok Woo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Cervical self-sampling is increasingly used for high-risk human papillomavirus (hrHPV) testing, but evidence for integrated liquid-based cytology (LBC) and sexually transmitted infection (STI) testing is limited. This study evaluated the feasibility and diagnostic agreement of an integrated single-step self-sampling approach for LBC, hrHPV, and STI testing.
Methods
In this prospective paired study, 520 Korean women for cervical cancer screening between December 2024 and February 2025 were enrolled. Each participant first underwent cervical self-sampling using Earlypap®, followed by clinician-collected sampling. Paired specimens were analyzed for LBC, hrHPV, and STI detection. Percentage agreement and Cohen’s kappa coefficients (κ) were calculated.
Results
Self-sampling was successful on the first attempt in 98.5% of participants, with 92.1% preferring it over clinician-collection. LSIL was detected in 2.3% of self-collected and 1.2% of clinician-collected specimens, and HSIL was detected in 0.4% of both specimen types. hrHPV positivity was 14.8% in self- and 12.9% in clinician-collected specimens. Ureaplasma spp. were frequently detected, and Candida albicans was identified in approximately 5% of specimens. Overall agreement was 91.7% (κ = 0.67) for LBC, 95.4% (κ = 0.79) for hrHPV, and 97.0% (κ = 0.72) for STI.
Conclusions
Integrated cervical self-sampling using a single-step device demonstrated high feasibility and substantial agreement with clinician-based sampling, supporting its potential to improve screening efficiency and reduce participation barriers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
- Department of Pathology, Chungbuk National University Hospital, Cheongju 28644, Republic of Korea.
- Motaean Woman Hospital, Cheongju 28628, Republic of Korea.
- Department of Health Policy and Management, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
- Department of Public Health and Preventive Medicine, Chungbuk National University Hospital, Cheongju 28644, Republic of Korea.
- Department of Preventive Medicine, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
ORCID-Profile: Chang Gok Woo, So Young Kim, Jong Hyock Park, Ok-Jun Lee
Zitieren
APA
Woo, C. G., Choi, J., Im, Y., Kim, M. K., Kim, S. Y., Park, J. H., & Lee, O. J. (2026). Integrated Cervical Self-Sampling for Cytology, High-Risk Human Papillomavirus, and Sexually Transmitted Infection Testing: A Prospective Study. Diagnostics, 16(12), 1863. https://doi.org/10.3390/diagnostics16121863
Vancouver
Woo CG, Choi J, Im Y, Kim MK, Kim SY, Park JH, et al. Integrated Cervical Self-Sampling for Cytology, High-Risk Human Papillomavirus, and Sexually Transmitted Infection Testing: A Prospective Study. Diagnostics. 2026;16(12):1863. doi:10.3390/diagnostics16121863
BibTeX
@article{Woo2026,
author = {Woo, Chang Gok and Choi, Jaehoon and Im, Yujin and Kim, Man Ki and Kim, So Young and Park, Jong Hyock and Lee, Ok-Jun},
title = {Integrated Cervical Self-Sampling for Cytology, High-Risk Human Papillomavirus, and Sexually Transmitted Infection Testing: A Prospective Study},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {12},
pages = {1863},
doi = {10.3390/diagnostics16121863}
}
EUVIMED